Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Melatonin and Donepezil in Children with ASD
NCT02487082Phase 2Terminated
- Sponsor
- Stony Brook University
- Start
- Jun 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of donepezil and melatonin in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Stony Brook University. Primary endpoint: Aberrant Behavior Checklist (ABC) Lethargy/Social Withdrawal Subscale. Started Jun 2015; status: terminated.
02
Drugs
donepezilmelatonin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02487082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02487082.